Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement

By afschroeder • January 19, 2026

Greenland JR, Perch M, Halloran K, Levine DJ, Morrell ED, Reed A, Shaver CM, Singer JP, Sweet SC, Vos R, Aryal S, Avdimiretz N, Burrows F, Calabrese D, Calabrese F, Campos S, Combs M, de Perrot M, Dellgren G, Diamond JM, Egan T, Ging P, Glidden DV, Goddard M, Jyothula S, Keller M, Kulkarni H, Kwakkel-van Erp JM, Lama V, Marczin N, Martinu T, Neely ML, Palmer SM, Patterson CM, Pavlisko EN, Pham C, Sanchez M, Schultz HHL, Schwerk N, Shah U, Shashaty M, Singer L, Smith P, Snyder LD, Solomon M, Verleden S, Verplancke V, Zeevi A, Todd JL. Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement. J Heart Lung Transplant. 2026 Feb;45(2):168-171. doi: 10.1016/j.healun.2025.09.016. PMID: 41548963.

Tags: Antibody-mediated rejection (AMR), Chronic lung allograft dysfunction (CLAD), Clinical trial endpoints, Lung transplantation, Patient-reported outcomes (PROs), Primary Graft Dysfunction, Publications, Pulmonary, Critical Care & Sleep Medicine

Rising trends in infant ER encounters for food-induced allergic reactions in the era of early allergenic food introduction

Chin A, Doroudchi A, Pham DC, Jackson NJ, Garcia-Lloret MI. Rising trends in infant ER encounters for food-induced allergic reactions in the era of early[...]

Kappa-Restricted IgA Nephropathy Treated Successfully With Targeted-Release Budesonide

Neinast M, Zuckerman JE, Khorsan R, Nobakht N, Kamgar M, Sarkar M, Kamal F, Arman F. Kappa-Restricted IgA Nephropathy Treated Successfully With Targeted-Release Budesonide. Kidney[...]

Spontaneous Heparin-Induced Thrombocytopenia Following Orthopedic Surgery

Korolyov A, Hu R. Spontaneous Heparin-Induced Thrombocytopenia Following Orthopedic Surgery. Cureus. 2025 Dec 15;17(12):e99312. doi: 10.7759/cureus.99312. PMID: 41552073; PMCID: PMC12805603.